Device Trial Radar · NCT04735016
DiamondTemp Global Registry
Last checked: Nov 19, 2026Latest source record: Nov 12, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
545
Planned (sponsor's estimate)
Start
Apr 22, 2021
Primary completion
Dec 31, 2026
Study completion Dec 31, 2026
Sponsor
- Lead sponsor
- Medtronic Cardiac Ablation SolutionsPublic (MDT)
- Sponsor type
- Industry
- First posted
- Feb 2, 2021
Design
- Study type
- Observational
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The DiamondTemp™ Global Registry is a prospective, global, multi-center, observational post-market registry.
Conditions
- Arrhythmia
Interventions
DiamondTemp™ Ablation SystemDevice
A cardiac ablation will be performed using the DiamondTemp™ Ablation System.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Freedom from Recurrence at 12 MonthsTime frame: 12 Months
- Freedom from Device / Procedure Related Adverse EventsTime frame: 12 Months
Locations
21 sites in 12 countries. Site status is shown where the registry gives one.
Sunshine Coast University Hospital
Birtinya, Australia
Fiona Stanley Hospital
Murdoch, Australia
Universitair Ziekenhuis Brussel
Jette, Belgium
18 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.